{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:53:52Z","timestamp":1792180432001,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ningbo Top Medical and Health Research Program","award":["2023010211"],"award-info":[{"award-number":["2023010211"]}]},{"name":"Zhejiang Provincial Medicine and Health Research Foundation","award":["2023KY040"],"award-info":[{"award-number":["2023KY040"]}]},{"name":"Zhejiang Provincial Medicine and Health Research Foundation","award":["2024KY1584"],"award-info":[{"award-number":["2024KY1584"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00428-025-04289-x","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T23:21:52Z","timestamp":1761780112000},"page":"263-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["FLCN-mutated eosinophilic renal tumors: clinicopathologic and molecular analysis of five cases highlighting morphologic heterogeneity"],"prefix":"10.1007","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-7303","authenticated-orcid":false,"given":"Ming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"5","key":"4289_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000516046","volume":"88","author":"A Cimadamore","year":"2021","unstructured":"Cimadamore A, Lopez-Beltran A, Scarpelli M et al (2021) The wide spectrum of oncocytic changes and tumors in the kidney: splitting and lumping. Pathobiology 88(5):323\u2013326. https:\/\/doi.org\/10.1159\/000516046","journal-title":"Pathobiology"},{"issue":"9","key":"4289_CR2","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41379-022-01057-z","volume":"35","author":"O Hes","year":"2022","unstructured":"Hes O, Trpkov K (2022) Do we need an updated classification of oncocytic renal tumors?\u202f: emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities. Mod Pathol 35(9):1140\u20131150. https:\/\/doi.org\/10.1038\/s41379-022-01057-z","journal-title":"Mod Pathol"},{"issue":"10","key":"4289_CR3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41379-022-01108-5","volume":"35","author":"MB Amin","year":"2022","unstructured":"Amin MB, McKenney JK, Martignoni G et al (2022) Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis. Mod Pathol 35(10):1306\u20131316. https:\/\/doi.org\/10.1038\/s41379-022-01108-5","journal-title":"Mod Pathol"},{"issue":"5","key":"4289_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00428-024-03909-2","volume":"485","author":"SK Mohanty","year":"2024","unstructured":"Mohanty SK, Lobo A, Jha S et al (2024) Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. Virchows Arch 485(5):829\u2013840. https:\/\/doi.org\/10.1007\/s00428-024-03909-2","journal-title":"Virchows Arch"},{"issue":"6","key":"4289_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/PAP.0000000000000321","volume":"28","author":"A Hamza","year":"2021","unstructured":"Hamza A, Sirohi D, Smith SC et al (2021) Low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: an update on biologic potential, morphologic spectrum, and differential diagnosis with other low-grade oncocytic tumors. Adv Anat Pathol 28(6):396\u2013407. https:\/\/doi.org\/10.1097\/PAP.0000000000000321","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"4289_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/PAP.0000000000000335","volume":"29","author":"S Gupta","year":"2022","unstructured":"Gupta S, Menon S, Raghunathan A et al (2022) Do we have sufficient evidence to define prognosis for \u201cLow-grade\u201d fumarate fydratase-deficient renal cell carcinoma? Adv Anat Pathol 29(3):178\u2013181. https:\/\/doi.org\/10.1097\/PAP.0000000000000335","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"4289_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.semdp.2024.01.008","volume":"41","author":"J Wu","year":"2024","unstructured":"Wu J, Lu J, Wu CL et al (2024) Birt-hogg-dub\u00e9 syndrome in an overall view: focus on the clinicopathological prospects in renal tumors. Semin Diagn Pathol 41(3):119\u2013124. https:\/\/doi.org\/10.1053\/j.semdp.2024.01.008","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"4289_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/his.13277","volume":"72","author":"AJ Gill","year":"2018","unstructured":"Gill AJ (2018) Succinate dehydrogenase (SDH)-deficient neoplasia. Histopathology 72(1):106\u2013116. https:\/\/doi.org\/10.1111\/his.13277","journal-title":"Histopathology"},{"issue":"10","key":"4289_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/genes12101585","volume":"12","author":"EP Henske","year":"2021","unstructured":"Henske EP, Cornejo KM, Wu CL (2021) Renal cell carcinoma in tuberous sclerosis complex. Genes 12(10):1585. https:\/\/doi.org\/10.3390\/genes12101585","journal-title":"Genes"},{"issue":"16","key":"4289_CR10","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.3390\/cancers15164043","volume":"15","author":"P Kapur","year":"2023","unstructured":"Kapur P, Brugarolas J, Trpkov K (2023) Recent advances in renal tumors with TSC\/mTOR pathway abnormalities in patients with tuberous sclerosis complex and in the sporadic setting. Cancers (Basel) 15(16):4043. https:\/\/doi.org\/10.3390\/cancers15164043","journal-title":"Cancers (Basel)"},{"issue":"10","key":"4289_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrurol.2015.206","volume":"12","author":"LS Schmidt","year":"2015","unstructured":"Schmidt LS, Linehan WM (2015) Molecular genetics and clinical features of Birt-Hogg-Dub\u00e9 syndrome. Nat Rev Urol 12(10):558\u2013569. https:\/\/doi.org\/10.1038\/nrurol.2015.206","journal-title":"Nat Rev Urol"},{"issue":"12","key":"4289_CR12","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","volume":"26","author":"CP Pavlovich","year":"2002","unstructured":"Pavlovich CP, Walther MM, Eyler RA et al (2002) Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome. Am J Surg Pathol 26(12):1542\u20131552. https:\/\/doi.org\/10.1097\/00000478-200212000-00002","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4289_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/cas.14255","volume":"111","author":"M Furuya","year":"2020","unstructured":"Furuya M, Hasumi H, Yao M et al (2020) Birt-Hogg-Dub\u00e9 syndrome-associated renal cell carcinoma: histopathological features and diagnostic conundrum. Cancer Sci 111(1):15\u201322. https:\/\/doi.org\/10.1111\/cas.14255","journal-title":"Cancer Sci"},{"key":"4289_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.03.012","author":"S Gupta","year":"2025","unstructured":"Gupta S, Dasari S, Warren RR et al (2025) Renal neoplasia in Birt-Hogg-Dub\u00e9 syndrome: integrated histopathologic, bulk, and single-cell transcriptomic analysis. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2025.03.012","journal-title":"Eur Urol"},{"issue":"10","key":"4289_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"JR Srigley","year":"2013","unstructured":"Srigley JR, Delahunt B, Eble JN et al (2013) The international society of urological pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37(10):1469\u20131489. https:\/\/doi.org\/10.1097\/PAS.0b013e318299f2d1","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4289_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/PAS.0000000000002152","volume":"48","author":"XM Wang","year":"2024","unstructured":"Wang XM, Mannan R, Zhang Y et al (2024) Hybrid oncocytic tumors (HOTs) in Birt-Hogg-Dub\u00e9 syndrome patients-a tale of two cities: sequencing analysis reveals dual lineage markers capturing the 2 cellular populations of HOT. Am J Surg Pathol 48(2):163\u2013173. https:\/\/doi.org\/10.1097\/PAS.0000000000002152","journal-title":"Am J Surg Pathol"},{"key":"4289_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104596","volume":"92","author":"R Jikuya","year":"2023","unstructured":"Jikuya R, Johnson TA, Maejima K et al (2023) Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma. EBioMedicine 92:104596. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104596","journal-title":"EBioMedicine"},{"issue":"15","key":"4289_CR18","first-page":"4583","volume":"63","author":"SK Khoo","year":"2003","unstructured":"Khoo SK, Kahnoski K, Sugimura J et al (2003) Inactivation of BHD in sporadic renal tumors. Cancer Res 63(15):4583\u20134587","journal-title":"Cancer Res"},{"issue":"11","key":"4289_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1136\/jmg.40.11.820","volume":"40","author":"NF da Silva","year":"2003","unstructured":"da Silva NF, Gentle D, Hesson LB et al (2003) Analysis of the Birt-Hogg-Dub\u00e9 (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer. J Med Genet 40(11):820\u2013824. https:\/\/doi.org\/10.1136\/jmg.40.11.820","journal-title":"J Med Genet"},{"issue":"2","key":"4289_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.bjc.6603492","volume":"96","author":"S Gad","year":"2007","unstructured":"Gad S, Lef\u00e8vre SH, Khoo SK et al (2007) Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma. Br J Cancer 96(2):336\u2013340. https:\/\/doi.org\/10.1038\/sj.bjc.6603492","journal-title":"Br J Cancer"},{"key":"4289_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002413","author":"P Argani","year":"2025","unstructured":"Argani P, Baraban E, Yaskiv O et al (2025) Clinically sporadic Folliculin-mutated renal epithelial neoplasms represent a mixture of true somatic Folliculin-mutated and occult Birt-Hogg-Dub\u00e9 syndrome-associated cases: morphologic and molecular overlap with TSC\/MTOR-mutated eosinophilic renal neoplasms and MiT family translocation renal cell carcinoma. Am J Surg Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000002413","journal-title":"Am J Surg Pathol"},{"key":"4289_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105813","volume":"160","author":"S Gupta","year":"2025","unstructured":"Gupta S, Dasari S, Shen W et al (2025) Morphologic and immunophenotypic characterization of conventional FLCN-mutated tumors (FMT) compared to a series of 8 non-conventional FMT. Hum Pathol 160:105813. https:\/\/doi.org\/10.1016\/j.humpath.2025.105813","journal-title":"Hum Pathol"},{"key":"4289_CR23","doi-asserted-by":"publisher","unstructured":"Xia QY, Wang XT, Zhang HZ et al (2025) GPNMB expression identifies FLCN-associated eosinophilic renal tumors with heterogeneous clinicopathologic spectrum and gene expression profiles. Am J Surg Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000002435","DOI":"10.1097\/PAS.0000000000002435"},{"issue":"3","key":"4289_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cas.12601","volume":"106","author":"M Furuya","year":"2015","unstructured":"Furuya M, Hong SB, Tanaka R et al (2015) Distinctive expression patterns of glycoprotein non\u2010metastatic B and folliculin in renal tumors in patients with Birt\u2013Hogg\u2013Dub\u00e9 syndrome. Cancer Sci 106(3):315\u2013323. https:\/\/doi.org\/10.1111\/cas.12601","journal-title":"Cancer Sci"},{"issue":"2","key":"4289_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/path.5875","volume":"257","author":"DC Salles","year":"2022","unstructured":"Salles DC, Asrani K, Woo J et al (2022) GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms. J Pathol 257(2):158\u2013171. https:\/\/doi.org\/10.1002\/path.5875","journal-title":"J Pathol"},{"issue":"12","key":"4289_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015793","volume":"5","author":"SB Hong","year":"2010","unstructured":"Hong SB, Oh H, Valera VA et al (2010) Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS ONE 5(12):e15793. https:\/\/doi.org\/10.1371\/journal.pone.0015793","journal-title":"PLoS ONE"},{"issue":"7826","key":"4289_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano G, Di Malta C, Esposito A et al (2020) A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dub\u00e9 syndrome. Nature 585(7826):597\u2013602. https:\/\/doi.org\/10.1038\/s41586-020-2444-0","journal-title":"Nature"},{"issue":"1","key":"4289_CR28","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1038\/s41467-022-34617-7","volume":"13","author":"K Asrani","year":"2022","unstructured":"Asrani K, Woo J, Mendes AA et al (2022) An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss. Nat Commun 13(1):6808. https:\/\/doi.org\/10.1038\/s41467-022-34617-7","journal-title":"Nat Commun"},{"issue":"1","key":"4289_CR29","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.14670\/HH-27.1407","volume":"27","author":"N Kuroda","year":"2012","unstructured":"Kuroda N, Tanaka A, Ohe C et al (2012) Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects. Histol Histopathol 27(1):1407\u20131412. https:\/\/doi.org\/10.14670\/HH-27.1407","journal-title":"Histol Histopathol"},{"issue":"5","key":"4289_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-023-03673-9","volume":"483","author":"C Ricci","year":"2023","unstructured":"Ricci C, Ambrosi F, Franceschini T et al (2023) Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT. Virchows Arch 483(5):687\u2013698. https:\/\/doi.org\/10.1007\/s00428-023-03673-9","journal-title":"Virchows Arch"},{"issue":"1","key":"4289_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","volume":"43","author":"YB Chen","year":"2019","unstructured":"Chen YB, Mirsadraei L, Jayakumaran G et al (2019) Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm. Am J Surg Pathol 43(1):121\u2013131. https:\/\/doi.org\/10.1097\/PAS.0000000000001170","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4289_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/PAS.0b013e31818cb8f5","volume":"33","author":"MB Amin","year":"2009","unstructured":"Amin MB, Gupta R, Ondrej H et al (2009) Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol 33(3):393\u2013400. https:\/\/doi.org\/10.1097\/PAS.0b013e31818cb8f5","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04289-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:53:09Z","timestamp":1771404789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04289-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4289"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04289-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki. This study was approved by the Institutional Review Boards Committee of the authors\u2019 institutions. Written informed consent for participation was not required for this study in accordance with the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}